{"id":"nct:NCT04642339","kind":"trial","title":"Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela","authors":["Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation"],"author_count":1,"year":2020,"published":"2020-11-24","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT04642339","source_url":"https://clinicaltrials.gov/study/NCT04642339","archive_url":"https://space-kitty.com/papers/nct:NCT04642339","updated":"2020-11-24","pmid":null,"pmcid":null,"openalex_id":null,"pdf_url":null,"abstract":"Randomized, double-blind, placebo controlled clinical trial of immunogenicity, safety and efficacy of the Gam-COVID-Vac combined vector vaccine against the SARS-CoV-2-induced coronavirus infection in adults.","abstract_license":"ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters","license":"ClinicalTrials.gov terms (attribution, processing date, modifications noted)","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Covid19"],"details":{"acronym":"VENEZUELA","status":"UNKNOWN","phase":"PHASE3","study_type":"INTERVENTIONAL","enrollment":2000,"sponsor":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","conditions":["Covid19"],"interventions":["BIOLOGICAL: Gam-COVID-Vac","BIOLOGICAL: Placebo"],"start_date":"2020-11-01","start_date_type":"ESTIMATED","primary_completion_date":"2021-10-01","has_results":false,"data_source":"ClinicalTrials.gov","data_processed":"2026-10-29T09:00:05","modifications":"selected fields only; whitespace normalized; brief summary truncated to 2,000 characters"},"provenance":"clinicaltrials","attribution":"Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.","topics":[{"slug":"neurodegeneration","name":"Alzheimer's, Parkinson's & Neurodegeneration","domain_slug":"medicine"}],"cited_in_dossiers":[]}